Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates
TRAF6 靶向纳米免疫疗法对动脉粥样硬化小鼠和非人类灵长类动物的疗效和安全性评估
期刊:Nature Biomedical Engineering
影响因子:26.8
doi:10.1038/s41551-018-0221-2
Marnix Lameijer, Tina Binderup, Mandy M T van Leent, Max L Senders, Francois Fay, Joost Malkus, Brenda L Sanchez-Gaytan, Abraham J P Teunissen, Nicolas Karakatsanis, Philip Robson, Xianxiao Zhou, Yuxiang Ye, Gregory Wojtkiewicz, Jun Tang, Tom T P Seijkens, Jeffrey Kroon, Erik S G Stroes, Andreas Kja
